Intracellular restriction factors in mammalian cells - An ancient defense system finds a modern foe

被引:27
作者
Baumann, JG [1 ]
机构
[1] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA
关键词
retroviruses; restriction; APOBEC; Trim5; Fv-1; vif; lentiviruses; HIV;
D O I
10.2174/157016206776055093
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cross-species transmission of retroviruses poses a threat to mammalian species. Zoonoses have given rise to devastating diseases because the host organism is not prepared to resist a new pathogen. Mammals have developed several layers of defense against viruses, including an intracellular antiretroviral defense, a part of innate immunity. Retroviral restrictions had been studied for decades using murine leukemia virus in mice, however it has become clear that primates too have intrinsic mechanisms to ward off infections by retroviruses. Several of these antiretroviral restriction mechanisms have recently been identified, with two particularly well described factors being members of the tripartite motif (Trim) and APOBEC families. Both systems provide a strong barrier against lentiviral infections. The viruses have developed Countermeasures that allow them to replicate despite the host factors. This review discusses our current knowledge of this ancient battle between mammalian hosts and their retroviral opponents.
引用
收藏
页码:141 / 168
页数:28
相关论文
共 410 条
[1]   Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells [J].
Aagaard, L ;
Mikkelsen, JG ;
Warming, S ;
Duch, M ;
Pedersen, FS .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :439-442
[2]   Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies [J].
Adamson, AL ;
Kenney, S .
JOURNAL OF VIROLOGY, 2001, 75 (05) :2388-2399
[3]   High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the gag precursor at the p2/nucleocapsid processing site [J].
Akari, H ;
Fujita, M ;
Kao, S ;
Khan, MA ;
Shehu-Xhilaga, M ;
Adachi, A ;
Strebel, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12355-12362
[4]   APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein [J].
Alce, TM ;
Popik, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) :34083-34086
[5]   MUTATIONS OF RNA AND PROTEIN SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING RESULT IN PRODUCTION OF NONINFECTIOUS VIRUS [J].
ALDOVINI, A ;
YOUNG, RA .
JOURNAL OF VIROLOGY, 1990, 64 (05) :1920-1926
[6]   The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse [J].
Alexander, WS ;
Hilton, DJ .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :503-529
[7]   Cu17/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation [J].
Ali, SH ;
Kasper, JS ;
Arai, T ;
DeCaprio, JA .
JOURNAL OF VIROLOGY, 2004, 78 (06) :2749-2757
[8]   APOBEC3G genetic variants and their influence on the progression to AIDS [J].
An, P ;
Bleiber, G ;
Duggal, P ;
Nelson, G ;
May, M ;
Mangeat, B ;
Alobwede, I ;
Trono, D ;
Vlahov, D ;
Donfield, S ;
Goedert, JJ ;
Phair, J ;
Buchbinder, S ;
O'Brien, SJ ;
Telenti, A ;
Winkler, CA .
JOURNAL OF VIROLOGY, 2004, 78 (20) :11070-11076
[9]   ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing [J].
Anant, S ;
Mukhopadhyay, D ;
Sankaranand, V ;
Kennedy, S ;
Henderson, JO ;
Davidson, NO .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 281 (06) :C1904-C1916
[10]   HOST-CONTROLLED MODIFICATION OF BACTERIOPHAGE [J].
ARBER, W .
ANNUAL REVIEW OF MICROBIOLOGY, 1965, 19 :365-+